Parallel Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $411K | Sell |
4,302
-827
| -16% | -$79.4K | 0.01% | 887 |
|
|
2026
Q1 | $532K | Buy |
5,129
+1,334
| +35% | +$151K | 0.01% | 698 |
|
|
2025
Q4 | $383K | Sell |
3,795
-578
| -13% | -$62.8K | 0.01% | 785 |
|
|
2025
Q3 | $539K | Buy |
4,373
+478
| +12% | +$59.3K | 0.01% | 633 |
|
|
2025
Q2 | $468K | Sell |
3,895
-434
| -10% | -$57.9K | 0.01% | 657 |
|
|
2025
Q1 | $637K | Sell |
4,329
-677
| -14% | -$103K | 0.01% | 509 |
|
|
2024
Q4 | $813K | Buy |
5,006
+500
| +11% | +$81.8K | 0.02% | 448 |
|
|
2024
Q3 | $734K | Buy |
4,506
+322
| +8% | +$47.7K | 0.02% | 455 |
|
|
2024
Q2 | $571K | Buy |
4,184
+22
| +0.5% | +$3.06K | 0.01% | 498 |
|
|
2024
Q1 | $637K | Buy |
4,162
+275
| +7% | +$41K | 0.02% | 459 |
|
|
2023
Q4 | $554K | Buy |
3,887
+354
| +10% | +$47.2K | 0.02% | 458 |
|
|
2023
Q3 | $463K | Sell |
3,533
-94
| -3% | -$14.3K | 0.02% | 477 |
|
|
2023
Q2 | $577K | Buy |
3,627
+44
| +1% | +$7.1K | 0.02% | 435 |
|
|
2023
Q1 | $567K | Buy |
3,583
+1,301
| +57% | +$195K | 0.02% | 429 |
|
|
2022
Q4 | $320K | Sell |
2,282
-110
| -5% | -$15.6K | 0.01% | 535 |
|
|
2022
Q3 | $307K | Buy |
2,392
+589
| +33% | +$85K | 0.01% | 530 |
|
|
2022
Q2 | $254K | Sell |
1,803
-150
| -8% | -$21.4K | 0.01% | 588 |
|
|
2022
Q1 | $272K | Sell |
1,953
-501
| -20% | -$76.8K | 0.01% | 613 |
|
|
2021
Q4 | $428K | Buy |
2,454
+140
| +6% | +$23.3K | 0.02% | 487 |
|
|
2021
Q3 | $383K | Sell |
2,314
-248
| -10% | -$42.7K | 0.02% | 480 |
|
|
2021
Q2 | $461K | Sell |
2,562
-200
| -7% | -$36.5K | 0.02% | 405 |
|
|
2021
Q1 | $533K | Sell |
2,762
-307
| -10% | -$59.1K | 0.03% | 336 |
|
|
2020
Q4 | $620K | Sell |
3,069
-448
| -13% | -$92.7K | 0.03% | 289 |
|
|
2020
Q3 | $739K | Buy |
3,517
+206
| +6% | +$45.9K | 0.05% | 232 |
|
|
2020
Q2 | $726K | Buy |
3,311
+204
| +7% | +$40.8K | 0.05% | 232 |
|
|
2020
Q1 | $538K | Buy |
3,107
+1,897
| +157% | +$313K | 0.04% | 229 |
|
|
2019
Q4 | $186K | Buy |
1,210
+87
| +8% | +$13K | 0.01% | 535 |
|
|
2019
Q3 | $171K | Buy |
1,123
+94
| +9% | +$14.9K | 0.01% | 531 |
|
|
2019
Q2 | $158K | Sell |
1,029
-213
| -17% | -$32.5K | 0.02% | 512 |
|
|
2019
Q1 | $199K | Buy |
1,242
+224
| +22% | +$34.8K | 0.02% | 401 |
|
|
2018
Q4 | $156K | Hold |
1,018
| – | – | 0.02% | 422 |
|
|
2018
Q3 | $153K | Buy |
1,018
+1
| +0.1% | +$142 | 0.02% | 469 |
|
|
2018
Q2 | $137K | Sell |
1,017
-554
| -35% | -$68.4K | 0.02% | 458 |
|
|
2018
Q1 | $209K | Sell |
1,571
-33
| -2% | -$4.43K | 0.03% | 312 |
|
|
2017
Q4 | $239K | Buy |
1,604
+8
| +0.5% | +$1.09K | 0.04% | 289 |
|
|
2017
Q3 | $216K | Buy |
1,596
+292
| +22% | +$39.2K | 0.04% | 302 |
|
|
2017
Q2 | $174K | Buy |
1,304
+157
| +14% | +$21.2K | 0.03% | 342 |
|
|
2017
Q1 | $150K | Buy |
1,147
+120
| +12% | +$15.5K | 0.03% | 353 |
|
|
2016
Q4 | $123K | Buy |
+1,027
| New | +$121K | 0.03% | 342 |
|
Other funds holding CLX
Parallel Advisors's CLX Position: Q2 2026 in Review
Parallel Advisors reduced its Clorox (CLX) stake by 16% in Q2 2026, selling an estimated $79.4K and leaving 4,302 shares worth $411K. The position accounts for 0.01% of the portfolio, ranked #887.
Parallel Advisors first reported a position in CLX in Q4 2016 and has held it in 39 quarters since. The position peaked at $813K in Q4 2024. 1,048 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Parallel Advisors held 4,302 shares of Clorox worth $411K as of Q2 2026.
- Parallel Advisors sold 827 Clorox shares in Q2 2026, an estimated $79.4K.
- Clorox made up 0.01% of Parallel Advisors's portfolio in Q2 2026, its #887 holding.
- Parallel Advisors first reported a position in Clorox in Q4 2016 and has held it in 39 quarters since.
- Parallel Advisors's Clorox position peaked at $813K in Q4 2024.
- 1,048 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.